Opportunity Information: Apply for RFA CA 13 021

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Research Answers to NCIs Provocative Questions Group C (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.399 Cancer Control.
  • This funding opportunity was created on Sep 30, 2013 and posted on Sep 30, 2013.
  • Applicants must submit their applications by Jun 20, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: Independent school districts Public and State controlled institutions of higher education Private institutions of higher education County governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Special district governments State governments Native American tribal governments (Federally recognized) Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Apply for RFA CA 13 021

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The funding opportunity titled "Research Answers to NCI's Provocative Questions - Group C (R21)" (Funding Opportunity Number RFA-CA-13-021) was a National Institutes of Health (NIH), National Cancer Institute (NCI) discretionary grant program aimed at pushing cancer researchers to tackle a curated set of underexplored, high-impact questions. The central idea behind the Provocative Questions initiative is that some important scientific problems in cancer research persist not because they are uninteresting, but because they are difficult, counterintuitive, or fall between traditional research silos. This FOA was designed to motivate fresh thinking and novel approaches to specific "problems and paradoxes" in cancer, framed explicitly as provocative questions, and to generate research answers that could unlock new directions for the field.

This particular announcement used the R21 mechanism, which is NIH's Exploratory/Developmental Grant format. In practical terms, that mechanism is commonly used to support early-stage, innovative, or high-risk projects where investigators may be testing a bold concept, building preliminary evidence for a new model, or developing an unconventional line of inquiry. The focus is less on having an already mature, fully proven research program and more on proposing an idea with strong rationale and potential for meaningful payoff if successful. Consistent with the R21 structure, the award ceiling listed for this FOA was $200,000, and the announcement specified that there was no cost sharing or matching requirement, meaning applicants were not required to contribute institutional or third-party funds as a condition of eligibility.

The scientific scope was broad across cancer research but anchored to NCI-defined priority questions rather than investigator-defined topic areas. The FOA emphasized that these provocative questions were not intended to represent the full set of NCI priorities in cancer research. Instead, they were meant to spotlight areas considered important yet historically insufficiently addressed. The goal, therefore, was to stimulate targeted innovation in specific domains where progress could be accelerated by encouraging researchers to directly confront unanswered paradoxes, gaps in understanding, or stubborn barriers to translation. The activity categories and associated CFDA numbers reflected the breadth of cancer-related work that could fit under this umbrella, including cancer cause and prevention research (93.393), cancer detection and diagnosis research (93.394), cancer treatment research (93.395), cancer biology research (93.396), and cancer control (93.399). Taken together, those categories indicate the FOA could support anything from mechanistic biology to intervention concepts, diagnostic strategies, and population-level or health services-related cancer research, as long as it squarely engaged one of the specified provocative questions in Group C.

Eligibility for the program was intentionally expansive and included a wide range of organizational types. Eligible applicants listed in the source data included public and state-controlled institutions of higher education, private institutions of higher education, nonprofits both with and without 501(c)(3) status (with the caveat noted in the listing), for-profit organizations other than small businesses, and small businesses. A variety of government entities were also eligible, including state governments, county governments, city or township governments, special district governments, independent school districts, and public housing authorities or Indian housing authorities. The FOA also allowed applications from Native American tribal governments (both federally recognized and other-than-federally recognized) and Native American tribal organizations. Beyond these standard categories, the announcement explicitly noted additional eligible applicants such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations and eligible federal agencies. Importantly, the eligibility language also included non-U.S. entities: non-domestic (non-U.S.) organizations and institutions could apply, non-domestic components of U.S. organizations were eligible, and foreign components as defined under NIH policy were allowed. That inclusion signals NCI's interest in drawing in global expertise and perspectives for these hard problems, recognizing that innovative answers may come from any geography or research ecosystem.

Administratively, the opportunity was posted and created on September 30, 2013, with an original and current closing date of June 20, 2014, and it was archived on July 21, 2014. In other words, this was a time-limited solicitation with a fixed submission window rather than an ongoing, continuously open mechanism. The opportunity category was discretionary, and the funding instrument type was a grant, consistent with NIH's standard competitive peer-reviewed research funding model. While the summary provided here does not include review criteria or application structure details, the intent and framing strongly imply that applications were expected to be especially responsive to the stated provocative questions and to propose genuinely innovative approaches rather than incremental extensions of well-trodden lines of work.

Overall, this FOA can be understood as a targeted push by NCI to catalyze exploratory, potentially high-risk cancer research that directly addresses specific, carefully selected scientific puzzles. By pairing the Provocative Questions concept with the R21 exploratory grant format and a wide eligibility net that included domestic and international applicants across academic, nonprofit, governmental, and commercial sectors, the program was set up to attract unconventional ideas and new combinations of expertise. The underlying message was that some cancer research bottlenecks persist because they have not been framed sharply enough, pursued creatively enough, or prioritized enough, and that focused investments in answering these pointed questions could open up new scientific and clinical opportunities.

For further details, the source announcement was hosted by NIH at: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-021.html, and the listed support contact for access or linking issues was the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

FAQs: Research Answers to NCI's Provocative Questions - Group C (R21) (RFA-CA-13-021)

What is the title and funding opportunity number for this grant?

The funding opportunity is titled "Research Answers to NCI's Provocative Questions - Group C (R21)" and the Funding Opportunity Number is RFA-CA-13-021.

Which agency offered this funding opportunity?

This was offered by the National Institutes of Health (NIH), National Cancer Institute (NCI).

What is the main purpose of the Provocative Questions initiative?

The Provocative Questions initiative is meant to push cancer researchers to address a curated set of important, underexplored scientific problems that tend to persist because they are difficult, counterintuitive, or fall between traditional research silos. The questions are framed as specific "problems and paradoxes" intended to unlock new directions for cancer research.

What does "Group C" mean in this announcement?

Based on the information provided, "Group C" refers to a subset of NCI-defined provocative questions. Applications were expected to directly address one of the specified provocative questions in Group C rather than proposing an investigator-defined topic.

What type of funding mechanism is used in this opportunity?

This opportunity used the NIH R21 mechanism, which is the Exploratory/Developmental Grant format.

What kinds of projects are typically supported under an R21?

R21 awards commonly support early-stage, innovative, or higher-risk projects. They are often used to test bold concepts, develop preliminary evidence for a new model, or pursue unconventional lines of inquiry. The emphasis is less on a fully mature research program and more on a strong rationale with potentially meaningful payoff if successful.

What is the award ceiling for this FOA?

The award ceiling listed for this FOA was $200,000.

Is cost sharing or matching required?

No. The announcement specified there was no cost sharing or matching requirement, meaning applicants were not required to contribute institutional or third-party funds as a condition of eligibility.

Is this an open-ended program or a time-limited solicitation?

This was a time-limited solicitation with a fixed submission window. The opportunity had an original and current closing date of June 20, 2014, and it was later archived.

When was the opportunity posted and when did it close?

It was posted/created on September 30, 2013. The closing date (both original and current) was June 20, 2014. The opportunity was archived on July 21, 2014.

What is the opportunity category and funding instrument type?

The opportunity category was discretionary, and the funding instrument type was a grant.

What scientific areas could be supported by this FOA?

The scientific scope was broad across cancer research, as long as the proposed work squarely addressed one of NCI's specified Group C provocative questions. The categories listed indicate potential coverage from mechanistic biology to intervention concepts, diagnostic strategies, and population-level or health services-related cancer research.

Does the FOA allow investigator-defined topics?

The focus was anchored to NCI-defined priority questions rather than investigator-defined topic areas. The provocative questions were used to direct applications toward specific under-addressed problems.

Are the provocative questions intended to represent all NCI priorities?

No. The FOA emphasized that the provocative questions were not intended to represent the full set of NCI priorities in cancer research. They were meant to spotlight important areas that were historically insufficiently addressed.

Which CFDA numbers (activity categories) are associated with this opportunity?

The listed CFDA categories were: cancer cause and prevention research (93.393), cancer detection and diagnosis research (93.394), cancer treatment research (93.395), cancer biology research (93.396), and cancer control (93.399).

What kinds of organizations were eligible to apply?

Eligibility was broad and included: public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (with and without 501(c)(3) status, with the caveat noted in the listing); for-profit organizations other than small businesses; and small businesses.

Are government entities eligible applicants?

Yes. Eligible government entities included state governments, county governments, city or township governments, special district governments, independent school districts, and public housing authorities or Indian housing authorities.

Are Native American tribal governments or organizations eligible?

Yes. The FOA allowed applications from Native American tribal governments (both federally recognized and other-than-federally recognized) and Native American tribal organizations.

Are minority-serving institutions specifically mentioned as eligible?

Yes. The listing explicitly noted eligibility for Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations were explicitly noted as eligible applicants.

Can federal agencies apply?

Yes. The eligibility language included eligible federal agencies.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The eligibility language included non-domestic (non-U.S.) organizations and institutions. It also allowed non-domestic components of U.S. organizations and foreign components as defined under NIH policy.

What does it mean that foreign components are allowed?

It means the announcement permitted foreign components as defined under NIH policy, indicating that certain international elements of a project (or project structures involving non-U.S. entities/components) could be included consistent with NIH rules.

What was the overall intent of this FOA?

The intent was to catalyze exploratory, potentially high-risk cancer research that directly addresses carefully selected scientific puzzles ("provocative questions"). The program was structured to attract unconventional ideas and new combinations of expertise across a wide range of eligible organizations, including international applicants.

Does the provided summary include review criteria or detailed application instructions?

No. The provided information does not include review criteria or application structure details, though it indicates applications were expected to be highly responsive to the stated provocative questions and to propose genuinely innovative approaches rather than incremental work.

Where was the original source announcement hosted?

The source announcement was hosted by NIH at: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-021.html

Who is the listed contact for access or linking issues?

The listed support contact for access or linking issues was the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.

Is this funding opportunity still active?

No. Based on the provided information, the opportunity closed on June 20, 2014 and was archived on July 21, 2014.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Research Answers to NCIs Provocative Questions Group E (R01)

Previous opportunity: Research Answers to NCIs Provocative Questions Group B (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 13 021

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 13 021) also looked into and applied for these:

Funding Opportunity
Research Answers to NCIs Provocative Questions Group E (R01) Apply for RFA CA 13 024

Funding Number: RFA CA 13 024
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Research Answers to NCIs Provocative Questions Group E (R21) Apply for RFA CA 13 025

Funding Number: RFA CA 13 025
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Interpreting Variation in Human Non Coding Genomic Regions Using Computational Approaches and Experimental Assessment (R01) Apply for RFA HG 13 013

Funding Number: RFA HG 13 013
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Planning for a National Center for Particle Beam Radiation Therapy Research (P20) Apply for PAR 13 371

Funding Number: PAR 13 371
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Research on Malignancies in the Context of HIV/AIDS (R21) Apply for PA 13 378

Funding Number: PA 13 378
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Research on Malignancies in the Context of HIV/AIDS (R01) Apply for PA 13 377

Funding Number: PA 13 377
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Sub Saharan African Collaborative HIV and Cancer Consortia (U54) Apply for RFA CA 13 010

Funding Number: RFA CA 13 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $750,000
FY 2014 American Schools and Hospitals Abroad (ASHA) Program Apply for APS ASHA 14 000001

Funding Number: APS ASHA 14 000001
Agency: Agency for International Development
Category: Education Health
Funding Amount: $2,000,000
Cancer Detection, Diagnostic and Treatment Technologies for Global Health (UH2/UH3) Apply for RFA CA 13 015

Funding Number: RFA CA 13 015
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Population based Research Optimizing Screening through Personalized Regimens (PROSPR) Revision to Enhance the Collection of Cervical Cancer Screening Data (U54) Apply for RFA CA 14 001

Funding Number: RFA CA 14 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $650,000
Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 13 386

Funding Number: PAR 13 386
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Low Cost, Pragmatic, Patient Centered Randomized Controlled Intervention Trials (UH2/UH3) Apply for RFA HL 14 019

Funding Number: RFA HL 14 019
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R41/R42) Apply for PA 13 388

Funding Number: PA 13 388
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R43/R44) Apply for PA 13 387

Funding Number: PA 13 387
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Community Oncology Research Program(NCORP) Community Sites (UM1) Apply for RFA CA 13 013

Funding Number: RFA CA 13 013
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Community Oncology Research Program (NCORP) Research Bases (UM1) Apply for RFA CA 13 012

Funding Number: RFA CA 13 012
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UM1) Apply for RFA CA 13 014

Funding Number: RFA CA 13 014
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exceptional Unconventional Research Enabling Knowledge Acceleration (EUREKA) for Neuroscience and Disorders of the Nervous System (R01) Apply for RFA MH 14 214

Funding Number: RFA MH 14 214
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Indo US Collaborative Program on Affordable Medical Devices (R03) Apply for PAR 13 390

Funding Number: PAR 13 390
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $75,000
NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Apply for PAR 14 007

Funding Number: PAR 14 007
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $50,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 13 021", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.